Mody, Mayur D.
Saba, Nabil F.
Article History
First Online: 16 January 2020
Compliance with Ethical Standards
:
: Mayur D. Mody declares that he has no conflict of interest. Nabil F. Saba has received research funding from Bristol-Myers Squibb, Exelixis, and Champions Oncology; has served on advisory boards for Merck, Bristol-Myers Squibb, Rakuten, and GlaxoSmithKline; and has served on a data safety monitoring committee for Amgen.
: This article does not contain any studies with human or animal subjects performed by any of the authors.